Phase II Trial of Maintenance Treatment With IL2 and Zoledronate in Multiple Myeloma After Bone Marrow Transplantation: Biological and Clinical Results

BACKGROUND: Maintenance treatment after autologous bone marrow transplantation in multiple myeloma improves the outcome of patients. We designed a phase II clinical trial to evaluate the treatment with IL2 and zoledronate after autologous bone marrow transplantation in myeloma patients. METHODS: Pat...

Descripción completa

Detalles Bibliográficos
Autores principales: Fazzi, Rita, Petrini, Iacopo, Giuliani, Nicola, Morganti, Riccardo, Carulli, Giovanni, Dalla Palma, Benedetta, Notarfranchi, Laura, Galimberti, Sara, Buda, Gabriele
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7890401/
https://www.ncbi.nlm.nih.gov/pubmed/33613510
http://dx.doi.org/10.3389/fimmu.2020.573156

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7890401/
https://www.ncbi.nlm.nih.gov/pubmed/33613510
http://dx.doi.org/10.3389/fimmu.2020.573156

Ejemplares similares